Development, multi-ancestry international validation, algorithmic audit, and prospective silent trial evaluation of PRISM - A globally accessible, patient-oriented artificial intelligence-based model to predict the presence of clinically significant prost
Development, multi-ancestry international validation, algorithmic audit, and prospective silent trial evaluation of PRISM - A globally accessible, patient-oriented artificial intelligence-based model to predict the presence of clinically significant prost
PRISM 的开发、多祖先国际验证、算法审核和前瞻性静默试验评估 - 一种全球可访问、面向患者的基于人工智能的模型，用于预测具有临床意义的前列腺的存在
批准号：
479908
负责人：
Zlotta Alexandre R
金额：
$33.72万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2027-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer (PCa), the most common cancer in men, is a major public health issue in Canada and around the world. The economic burden of PCa is also rising. Existing tools to predict the individual risk of harboring clinically significant PCa (csPCa) a
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
